Post-kala-azar dermal leishmaniasis (PKDL), HIV and pulmonary tuberculosis

National Medical Journal of India

Volumn 23, Issue 2, 2010, Pages 88-89

  Das, V N R ^a   Pandey, K ^a   Verma, N ^a   Bimal, S ^a   Lal, C S ^a   Singh, D ^a   Das, P ^a  

^a RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CASE REPORT; COMPLICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LEISHMANIASIS, CUTANEOUS; LUNG TUBERCULOSIS; VISCERAL LEISHMANIASIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; FEMALE; HIV-1; HUMANS; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; TUBERCULOSIS, PULMONARY;

EID: 77953316243     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Zijlstra EE, El-Hassan AM. Leishmaniasis in Sudan: Post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 2001;95 (Suppl 1):S59-S76.
2. Thakur CP, Sinha PK, Singh RK, Hassan SM, Narain S. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India. Trans R Soc Trop Med Hyg 2000;94:696-7.
3. Sharma SK, Aggarwal G, Seth P, Saha PK. Increasing HIV seropositivity among adult tuberculosis patients in Delhi. Indian J Med Res 2003;117:239-42.
4. Ranjan A, Sur D, Singh VP, Siddique NA, Manna B, Lal CS, et al. Risk factors for Indian kala-azar. Am J Trop Med Hyg 2005;73:74-8.
5. Sundar S, Kumar K, Chakravarty J, Agrawal D, Agrawal S, Chhabra A, et al. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine. Trans R Soc Trop Med Hyg 2006;100:698-700.
6. Belay AD, Asafa Y, Mesure J, Davidson RN. Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy. Ann Trop Med Parasitol 2006;100:223-7.
7. Sharma MC, Gupta AK, Verma N, Das VN, Saran R, Kar SK. Demonstration of leishmania parasites in skin lesions of Indian post kala-azar dermal leishmaniasis (PKDL) cases. J Commun Dis 2000;32:67-8.
8. Salotra P, Singh R. Challenges in the diagnosis of post kala-azar dermal leishmaniasis. Indian J Med Res 2006;123:295-310.
9. Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, et al. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Natl Med J India 2005;18:131-3.
10. Thakur CP, Narain S, Kumar N, Hassan SM, Jha DK, Kumar A. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis. Ann Trop Med Parasitol 1997;91:611-16.
11. Pandey K, Sinha PK, Das VN, Kumar N, Hassan SM, Verma N, et al. HIV-1 infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient-a case report. Ann Trop Med Parasitol 2005;99:807-11.
12. Das VN, Pandey K, Kumar N, Hassan SM, Bimal S, Lal CS, et al. Visceral leishmaniasis and tuberculosis in patients with HIV co-infection. Southeast Asian J Trop Med Public Health 2006;37:18-21.